Merbach A E and Tóth E 2001 The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging (New York: Wiley)
Caravan P, Ellison J J, McMurry T J and Lauffer R B 1999 Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99 2293-352 (Pubitemid 30498114)
Corot C, Robert P, Idée J-M and Port M 2006 Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Deliv. Rev. 58 1471-504
Weissleder R, Cheng H C, Bogdanova A and Bogdanov A 1997 Magnetically labeled cells can be detected by MR imaging J. Magn. Reson. Imag. 7 258-63 (Pubitemid 28365670)
Bulte J W M, Ma L D, Magin R L, Kamman R L, Hulstaert C E, Go K G, The T H and De Leij L 1993 Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles Magn. Reson. Med. 29 32-7 (Pubitemid 23063066)
Roch A, Gossuin Y, Muller R N and Gillis P 2005 Superparamagnetic colloid suspensions: water magnetic relaxation and clustering J. Magn. Magn. Mater. 293 532-9 (Pubitemid 40608976)
Roch A, Muller R N and Gillis P 1999 Theory of proton relaxation induced by superparamagnetic particles J. Chem. Phys. 110 5403-11 (Pubitemid 129615822)
Cabella C, Geninatti Crich S, Corpillo D, Barge A, Ghirelli C, Bruno E, Lorusso V, Uggeri F and Aime S 2006 Cellular labeling with Gd(III) chelates: only high thermodynamic stabilities prevent the cells acting as 'sponges' of Gd3+ ions Contrast Media Mol. Imag. 1 23-9
Bridot J-L et al 2007 Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging J. Am. Chem. Soc. 129 5076-84 (Pubitemid 46651385)
Söderlind F, Pedersen H, Petoral R M Jr, Käll P-O and Uvdal K 2005 Synthesis and characterisation of Gd2O3 nanocrystals functionalised by organic acids J. Colloid Interface Sci. 288 140-8
Fortin M-A, Petoral R M Jr, Söderlind F, Klasson A, Engström M, Veres T, Käll P-O and Uvdal K 2007 Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5T magnetic resonance clinical scanning Nanotechnology 18 395501
Klasson A, Ahrén M, Hellqvist E, Söderlind F, Rosén A, Käll P-O, Uvdal K and Engström M 2008 Positive MRI contrast enhancement in THP-1 cells with Gd2O3 nanoparticles Contrast Media Mol. Imag. 3 106-11
Faucher L, Guay-Bégin A-A, Lagueux J, Cté M-F, Petitclerc and Fortin M-A 2010 Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI Contrast Media Mol. Imag. doi:10.1002/cmmi.420at press
Bridot J L et al 2009 Hybrid gadolinium oxide nanoparticles combining imaging and therapy J. Mater. Chem. 19 2328-35
Park J Y et al 2009 Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images ACS Nano 3 3663-9
Simon G, Bauer J, Saborovski O, Fu Y, Corot C, Wendland M and Daldrup-Link H 2006 T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning Eur. Radiol. 16 738-45 (Pubitemid 44149388)
Bazzi R et al 2003 Synthesis and luminescent properties of sub-5-nm lanthanide oxides nanoparticles J. Lumin. 102/103 445-50
Gossuin Y, Roch A, Muller R N and Gillis P 2002 An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents J. Magn. Reson. 158 36-42
Tóth, Helm L and Merbach A E 2002 Relaxivity of MRI contrast agents Top. Current Chem. 221 61-101
Vander Elst L, Maton F, Laurent S, Seghi F, Chapelle F and Muller R N 1997 A multinuclear MR study of Gd-EOB-DTPA: comprehensive preclinical characterization of an organ specific MRI contrast agent Magn. Reson. Med. 38 604-14 (Pubitemid 27419225)
McDonald M A and Watkin K L 2006 Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles Acad. Radiol. 13 421-7
Gossuin Y, Hocq A, Vuong Q L, Disch S, Hermann R P and Gillis P 2008 Physico-chemical and NMR relaxometric characterization of gadolinium hydroxide and dysprosium oxide nanoparticles Nanotechnology 19 475102
Gossuin Y, Roch A, Muller R N and Gillis P 2000 Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange Magn. Reson. Med. 43 237-43 (Pubitemid 30075446)
Vymazal J, Brooks R A, Zak O, McRill C, Shen C and Chiro G D 1992 T1 and T2 of ferritin at different field strengths: effect on MRI Magn. Reson. Med. 27 368-74
Rohrer M, Bauer H, Mintorovitch J, Requardt M and Weinmann H-J 2005 Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths Investig. Radiol. 40 715-24 (Pubitemid 41546838)
